Expected earnings - Helix Biopharma Corp.
Source: US Earnings Reports
Helix Biopharma Corp. (HBPCF) is expected to report for Q3 2025
Helix Biopharma Corp.
NASDAQ: HBPCF
HBPCF Trading
0.0% G/L:
$1.73 Last:
100 Volume:
$1.73 Open:
HBPCF Latest News
March 16, 2026 05:00:00 pm
Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026February 24, 2026 09:00:00 am
Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC LondonFebruary 05, 2026 04:30:00 pm
Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic DiseasesHBPCF Stock Data
$104,197,388
75,324,080
0.06%
20
N/A
Biotechnology & Life Sciences
Healthcare
CA
Toronto
